Erratum: Impaired myocardial blood flow reserve in subjects with metabolic syndrome analyzed using positron emission tomography and N-13 labeled ammonia (European Journal of Nuclear Medicine and Molecular Imaging DOI: 10.1007/s00259-009-1307-6);Impaired myocardial blood flow reserve in subjects with metabolic syndrome analyzed using positron emission tomography and N-13 labeled ammonia

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 2, 2010, Pages 368-376

  Teragawa, Hiroki ^a   Morita, Koichi ^b   Shishido, Hiroki ^c   Otsuka, Nobuaki ^c   Hirokawa, Yutaka ^c   Chayama, Kazuaki ^a   Tamaki, Nagara ^b   Kihara, Yasuki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Hiroshima Heiwa Clinic   (Japan)

Author keywords

Abnormal coronary microvascular response; Insulin resistance; Metabolic syndrome

Indexed keywords

ADENOSINE; ADIPONECTIN; AMMONIA; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN 13; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AORTA PRESSURE; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CORONARY VASCULAR RESISTANCE; HEART MUSCLE BLOOD FLOW; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; POSITRON EMISSION TOMOGRAPHY; REST; VASOMOTOR REFLEX;

AMMONIA; CORONARY CIRCULATION; CORONARY VESSELS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NITROGEN RADIOISOTOPES; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77949263006     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1551-9     Document Type: Erratum

References (39)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
2. AM McNeill WD Rosamond CJ Girman SH Golden MI Schmidt HE East, et al. 2005 The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study Diabetes Care 28 385 390 10.2337/diacare.28.2.385 15677797 (Pubitemid 40170944)
3. HM Lakka DE Laaksonen TA Lakka LK Niskanen E Kumpusalo J Tuomilehto, et al. 2002 The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2709 2716 10.1001/jama.288.21.2709 12460094 (Pubitemid 35403784)
4. S Malik ND Wong SS Franklin TV Kamath GJ L'Italien JR Pio, et al. 2004 Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults Circulation 110 1245 1250 10.1161/01.CIR.0000140677.20606.0E 15326067 (Pubitemid 39202340)
5. G Hu Q Qiao J Tuomilehto B Balkau K Borch-Johnsen K Pyorala 2004 Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women Arch Intern Med 164 1066 1076 10.1001/archinte.164.10.1066 15159263 (Pubitemid 38668985)
6. H Takeuchi S Saitoh S Takagi H Ohnishi J Ohhata T Isobe, et al. 2005 Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu Study Hypertens Res 28 203 208 10.1291/hypres.28.203 16097362 (Pubitemid 40812603)
7. AS Gami BJ Witt DE Howard PJ Erwin LA Gami VK Somers, et al. 2007 Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies J Am Coll Cardiol 49 403 414 10.1016/j.jacc.2006.09.032 1:CAS:528:DC%2BD2sXhtVCks7s%3D 17258085 (Pubitemid 46135879)
8. I Yokoyama T Ohtake S Momomura J Nishikawa Y Sasaki M Omata 1996 Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis Circulation 94 3232 3238 1:STN:280:DyaK2s7ktlWhsQ%3D%3D 8989134
9. T Tsukamoto K Morita M Naya C Katoh M Inubushi Y Kuge, et al. 2006 Myocardial flow reserve is influenced by both coronary artery stenosis severity and coronary risk factors in patients with suspected coronary artery disease Eur J Nucl Med Mol Imaging 33 1150 1156 10.1007/s00259-006-0082-x 16733686 (Pubitemid 44484470)
10. I Yokoyama T Ohtake S Momomura K Yonekura S Woo-Soo J Nishikawa, et al. 1998 Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM Diabetes 47 119 124 10.2337/diabetes.47.1.119 1:CAS:528:DyaK1cXivFantw%3D%3D 9421384
11. M Kozakova C Palombo L Pratali G Pittella F Galetta A L'Abbate 1997 Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography Hypertension 29 551 559 1:STN:280:DyaK2s7pt1yntw%3D%3D 9040437
12. M Naya T Tsukamoto M Inubushi K Morita C Katoh T Furumoto, et al. 2007 Elevated plasma plasminogen activator inhibitor type-1 is an independent predictor of coronary microvascular dysfunction in hypertension Circ J 71 348 353 10.1253/circj.71.348 1:CAS:528:DC%2BD2sXjsF2kt78%3D 17322633 (Pubitemid 46409537)
13. P Koepfli TF Hany CA Wyss M Namdar C Burger AV Konstantinidis, et al. 2004 CT attenuation correction for myocardial perfusion quantification using a PET/CT hybrid scanner J Nucl Med 45 537 542 15073247
14. M Namdar P Koepfli R Grathwohl PT Siegrist M Klainguti T Schepis, et al. 2006 Caffeine decreases exercise-induced myocardial flow reserve J Am Coll Cardiol 47 405 410 10.1016/j.jacc.2005.08.064 1:CAS:528:DC%2BD28XksFCnug%3D%3D 16412869 (Pubitemid 43063263)
15. GD Hutchins M Schwaiger KC Rosenspire J Krivokapich H Schelbert DE Kuhl 1990 Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging J Am Coll Cardiol 15 1032 1042 1:STN:280:DyaK3c7oslGmuw%3D%3D 2312957
16. RB Devereux EM Lutas PN Casale P Kligfield RR Eisenberg IW Hammond, et al. 1984 Standardization of M-mode echocardiographic left ventricular anatomic measurements J Am Coll Cardiol 4 1222 1230 1:STN:280:DyaL2M%2FlsFymsw%3D%3D 6238987
17. T Yoshizumi T Nakamura M Yamane AH Islam M Menju K Yamasaki, et al. 1999 Abdominal fat: standardized technique for measurement at CT Radiology 211 283 286 1:STN:280:DyaK1M3gsFCrsQ%3D%3D 10189485
18. TH Schindler J Cardenas JO Prior AD Facta MC Kreissl XL Zhang, et al. 2006 Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function J Am Coll Cardiol 47 1188 1195 10.1016/j.jacc.2005.10.062 1:CAS:528:DC%2BD28XisF2it7w%3D 16545651
19. MJ Quinones M Hernandez-Pampaloni H Schelbert I Bulnes-Enriquez X Jimenez G Hernandez, et al. 2004 Coronary vasomotor abnormalities in insulin-resistant individuals Ann Intern Med 140 700 708 15126253
20. B Pirat H Bozbas V Simsek A Yildirir LE Sade Y Gursoy, et al. 2008 Impaired coronary flow reserve in patients with metabolic syndrome Atherosclerosis 201 112 116 10.1016/j.atherosclerosis.2008.02.016 1:CAS:528:DC%2BD1cXht1KlsbfE 18374338
21. TH Schindler XL Zhang G Vincenti L Mhiri R Lerch HR Schelbert 2007 Role of PET in the evaluation and understanding of coronary physiology J Nucl Cardiol 14 589 603 10.1016/j.nuclcard.2007.05.006 17679069 (Pubitemid 47163562)
22. PY Liu JH Chen LJ Lin JK Liao 2007 Increased Rho kinase activity in a Taiwanese population with metabolic syndrome J Am Coll Cardiol 49 1619 1624 10.1016/j.jacc.2006.12.043 1:CAS:528:DC%2BD2sXkt1artLY%3D 17433952 (Pubitemid 46551629)
23. NH Buus M Bottcher F Hermansen M Sander TT Nielsen MJ Mulvany 2001 Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia Circulation 104 2305 2310 10.1161/hc4401.098293 1:CAS:528:DC%2BD3MXpt1Wltrw%3D 11696470
24. A Tawakol MA Forgione M Stuehlinger NM Alpert JP Cooke J Loscalzo, et al. 2002 Homocysteine impairs coronary microvascular dilator function in humans J Am Coll Cardiol 40 1051 1058 10.1016/S0735-1097(02)02069-7 1:CAS:528: DC%2BD38XnvVygsrg%3D 12354427 (Pubitemid 35041985)
25. HO Steinberg H Chaker R Leaming A Johnson G Brechtel AD Baron 1996 Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance J Clin Invest 97 2601 2610 10.1172/JCI118709 1:CAS:528:DyaK28XjsFKjsLY%3D 8647954
26. RT de Jongh EH Serne RG IJ G de Vries CD Stehouwer 2004 Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance Circulation 109 2529 2535 10.1161/01.CIR.0000129772.26647.6F 15136505 (Pubitemid 38720552)
27. AA Lteif K Han KJ Mather 2005 Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks Circulation 112 32 38 10.1161/CIRCULATIONAHA.104.520130 1:STN:280: DC%2BD2Mzks1Ggtg%3D%3D 15983246 (Pubitemid 40962566)
28. F Perticone R Ceravolo M Candigliota G Ventura S Iacopino F Sinopoli, et al. 2001 Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C Diabetes 50 159 165 10.2337/diabetes.50.1.159 1:CAS:528:DC%2BD3MXis1OmtA%3D%3D 11147782
29. S Kawashima M Yokoyama 2004 Dysfunction of endothelial nitric oxide synthase and atherosclerosis Arterioscler Thromb Vasc Biol 24 998 1005 10.1161/01.ATV.0000125114.88079.96 1:CAS:528:DC%2BD2cXkt1Ogt7g%3D 15001455 (Pubitemid 38737823)
30. M Montagnani H Chen VA Barr MJ Quon 2001 Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179) J Biol Chem 276 30392 30398 10.1074/jbc.M103702200 1:CAS:528:DC%2BD3MXmtFehtLc%3D 11402048
31. H Chen M Montagnani T Funahashi I Shimomura MJ Quon 2003 Adiponectin stimulates production of nitric oxide in vascular endothelial cells J Biol Chem 278 45021 45026 10.1074/jbc.M307878200 1:CAS:528:DC%2BD3sXoslWlt7s%3D 12944390 (Pubitemid 37377262)
32. DE Moller KD Kaufman 2005 Metabolic syndrome: a clinical and molecular perspective Annu Rev Med 56 45 62 10.1146/annurev.med.56.082103.104751 1:CAS:528:DC%2BD2MXisVSrsLg%3D 15660501 (Pubitemid 40299773)
33. Y Higashi S Sasaki K Nakagawa H Matsuura G Kajiyama T Oshima 2001 Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function J Am Coll Cardiol 37 863 870 10.1016/S0735-1097(00)01177-3 1:CAS:528:DC%2BD3MXitlKitb4%3D 11693763 (Pubitemid 32202456)
34. Y Higashi S Sasaki K Nakagawa H Matsuura T Oshima K Chayama 2002 Endothelial function and oxidative stress in renovascular hypertension N Engl J Med 346 1954 1962 10.1056/NEJMoa013591 1:CAS:528:DC%2BD38Xks1SqtLo%3D 12075056 (Pubitemid 34651355)
35. M Naya T Tsukamoto K Morita C Katoh T Furumoto S Fujii, et al. 2007 Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients J Am Coll Cardiol 50 1144 1149 10.1016/j.jacc.2007.06. 013 1:CAS:528:DC%2BD2sXhtVCmu7bI 17868805 (Pubitemid 47375012)
36. BC Solymoss MG Bourassa L Campeau A Sniderman M Marcil J Lesperance, et al. 2004 Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity Am J Cardiol 93 159 164 10.1016/j.amjcard.2003.09.032 14715340 (Pubitemid 38058723)
37. G Schillaci M Pirro G Vaudo F Gemelli S Marchesi C Porcellati, et al. 2004 Prognostic value of the metabolic syndrome in essential hypertension J Am Coll Cardiol 43 1817 1822 10.1016/j.jacc.2003.12.049 15145106 (Pubitemid 38622521)
38. BA Herzog L Husmann I Valenta O Gaemperli PT Siegrist FM Tay, et al. 2009 Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve J Am Coll Cardiol 54 150 156 10.1016/j.jacc.2009.02.069 19573732
39. I Yokoyama K Yonekura Y Inoue K Ohtomo R Nagai 2001 Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance J Nucl Cardiol 8 445 451 10.1067/mnc.2001.115517 1:STN:280:DC%2BD3Mvjtlyisg%3D%3D 11481566 (Pubitemid 32737369)